Showing results (21-30 of 73) with videos related to
Sort By:
Pageof 8
International Journal of Chronic Obstructive Pulmonary Disease|June 30, 2022
Characteristics of New Users of Single- and Multiple-Inhaler Triple Therapy for COPD in Primary Care in EnglandKieran J Rothnie, Sandra Joksaite, Leah B Sansbury, et al.International Journal of Chronic Obstructive Pulmonary Disease|October 2, 2019
Economic impact of delaying initiation with multiple-inhaler maintenance triple therapy in Spanish patients with chronic obstructive pulmonary diseaseAntoni Sicras Mainar, Alicia Huerta, Ruth Navarro Artieda, et al.Respiratory Medicine|June 6, 2024
The long-term clinical and economic benefits of treating advanced COPD patients with single-inhaler triple therapy in Quebec, Canada - The IMPACT trialNancy A Risebrough, Sara Mursleen, Kerigo Ndirangu, et al.ERJ Open Research|March 29, 2021
Cost-effectiveness analysis of a single-inhaler triple therapy for COPD in the UKElisabeth Fenwick, Alan Martin, Melanie Schroeder, et al.International Journal of Chronic Obstructive Pulmonary Disease|March 13, 2023
Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β2-Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in EnglandGema Requena, Victoria Banks, Alexandrosz Czira, et al.International Journal of Chronic Obstructive Pulmonary Disease|March 10, 2022
Disease Burden and Healthcare Utilization Among Patients with Chronic Obstructive Pulmonary Disease (COPD) in EnglandLeah B Sansbury, David A Lipson, Chanchal Bains, et al.Value in Health Regional Issues|August 12, 2022
Modeling the Health and Economic Burden of Chronic Obstructive Pulmonary Disease in China From 2020 to 2039: A Simulation StudyJeong-Eun Park, Luying Zhang, Yu-Fan Ho, et al.International Journal of Chronic Obstructive Pulmonary Disease|June 29, 2026
Profiles and Disease Burden of Patients with COPD Initiating Triple Therapy in ChinaXin Li, Jie Cao, Sune Hao, et al.ERJ Open Research|February 24, 2022
Is single-inhaler triple therapy for COPD cost-effective in the UK? The IMPACT trialAlan Martin, Dhvani Shah, Kerigo Ndirangu, et al.Journal of Clinical Epidemiology|April 11, 2013
Clinical experience may affect clinician compliance with assigned treatment in randomized trialsStephen D Walter, Afisi S Ismaila, Deborah J Cook, et al.Pageof 8